Indole‐3‐Propionic Acid Drives Dendritic H3K27 Acetylation to Enhance CD8 + T Cell Immunity in Hepatocellular Carcinoma
Authors:
Open Access
- 16 July 2026
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 117 (10) , 2705-2718
Abstract
Indole‐3‐propionic acid (IPA) is documented to improve the effectiveness of tumor immunotherapy via regulating anti‐tumor immunity. However, the impacts of IPA in hepatocellular carcinoma (HCC) patients undergoing sintilimab combined with bevacizumab (SCB) treatment remain unknown. This study investigated the effects and underlying mechanisms of IPA in SCB‐treated HCC. Serum, tumor tissue, fecal and lymph node tissue samples were collected from HCC patients with or without a response to SCB therapy. Humanized orthotopic and subcutaneous HCC NOG mouse models were established. IPA‐treated mouse dendritic cells (DCs) were co‐cultured with mouse CD8 + T‐cells, which were subsequently co‐cultured with Hepa1‐6 cells. IPA levels were elevated in the serum, tumor tissues, and feces of responders, and serum IPA levels were positively correlated with the proportion of IFN‐γ + CD8 + T cells in tumor tissues as well asac‐H3K27 and IL‐12A levels in lymph node DCs. IPA amplified the suppressive impact of SCB on tumor growth in HCC mice. Moreover, IPA increased ac‐H3K27 and IL‐12A levels in DCs and upregulated effector CD8 + T‐cell immunity in HCC mice. Administration of a CD8‐neutralizing antibody and injection of shIL‐12A‐transfected DCs weakened IPA‐mediated inhibition of HCC in vivo. Furthermore, the ac‐H3K27 inhibitor A‐485 suppressed IL‐12A expression and effector CD8 + T‐cell immunity induced by IPA, thereby promoting the proliferation, invasion, and migration of Hepa1‐6 cells in vitro. These findings demonstrate that IPA enhances the effect of SCB‐treated HCC by upregulating H3K27 acetylation to promote IL‐12A expression in DCs, thereby potentiating CD8 + T‐cell immunity, which provides a basis for its potential use as a clinical adjuvant therapy.Keywords
This publication has 36 references indexed in Scilit:
- Indole-3-propionic acid function through PXR and AhR, molecular signaling pathways, and antitoxic role in underlying diseasesThe Journal of Steroid Biochemistry and Molecular Biology, 2025
- Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancerCell, 2024
- Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axisBiomedicine & Pharmacotherapy, 2022
- Epigenetics in hepatocellular carcinomaSeminars in Cancer Biology, 2022
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 studyThe Lancet Oncology, 2021
- Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunityCell Metabolism, 2021
- Indole-3-propionic acid has chemical chaperone activity and suppresses endoplasmic reticulum stress-induced neuronal cell deathBiochemical and Biophysical Research Communications, 2019
- Dysfunction of antigen processing and presentation by dendritic cells in cancerMolecular Immunology, 2019
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Immunity, 2018
- RECIST 1.1—Update and clarification: From the RECIST committeeEuropean Journal of Cancer, 2016